Medical technology has already brought us snake robots and nanobots for surgery. The next bot on the list? An origami robot with a biodegradable frame that you swallow in an ice cube.
Research suggests there may be gender, racial and socio-economic disparities when it comes to robotic surgery.
Reviewing the arc of healthcare history over the first four decades of Modern Healthcare's existence as a part of Crain Communications, two major themes stand out. First, as a nation we have moved inexorably toward providing health insurance coverage for all of our citizens. Second, advancing...
Physicians and teaching hospitals received $7.52 billion in payments and investments from drug and device companies in 2015, according to information the CMS released Thursday from its Open Payments database.
Dutch conglomerate Royal Philips announced Tuesday that it has acquired PathXL, a Northern Ireland-based developer of software used for digital pathology image analysis, workflow and education.
An experimental vaccine for the Zika virus is due to begin human testing in coming weeks, after getting the green light from U.S. health officials.
Medical-device makers might soon have an easier time winning hefty financial damages from companies that infringe on their patents following a U.S. Supreme Court decision Monday.
Drugmaker Merck is buying Afferent Pharmaceuticals, a privately held biotechnology company developing a chronic cough medication.
After several years of disappointing financials, Boston Scientific Corp. is cutting costs in a global restructuring.
Zimmer Biomet Holdings, a major manufacturer of musculoskeletal devices, will buy spinal device company LDR Holding Corp. for $1 billion.
Ponder the fleeting nature of fortune. Last fall, Theranos CEO Elizabeth Holmes, 32, was deemed the “youngest self-made female billionaire” in the world by Forbes magazine. Her net worth today? Bupkis.
Edward-Elmhurst Health, based in Naperville, Ill., is investing $7 million in a growing MRI business, a deal that underscores how hospitals are responding to cost-conscious patients.